Value-oriented funds outperformed their growth counterparts, while international-stock funds fared better than their US peers ...

Shares of Medtronic PLC MDT shed 1.52% to $88.49 Tuesday, on what proved to be an all-around mixed trading session for the ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Geopolitical tensions are escalating to levels not seen in decades, global trade relationships face unprecedented strain, and ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

Medtronic Evolut TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients: Galway, Ireland Tuesday, April 1 ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...